Home

Fred Callori

CIK 1843393 · last filed 2026-06-24

Fred Callori is a corporate insider who has filed 16 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for LONA, was dated Jun 24, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

16

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LONA Director — $8.17 — $0 2 2026-06-24
Astria Therapeutics, Inc. (ATXS) Delisted Director — $12.58 — $0 6 2026-01-23
Landos Biopharma, Inc. (LABP) Delisted Director — $22.93 — $0 5 2024-05-23
Astria Therapeutics, Inc. (CATB) Delisted Director — $8.54 — $0 3 2021-06-02

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 LONA Grant (A) — $0 EDGAR
2026-05-07 LONA Grant (A) — $0 EDGAR
2026-01-23 Astria Therapeutics, Inc. (ATXS) Delisted Disp (D) — $0 EDGAR
2025-06-12 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) — $0 EDGAR
2024-06-06 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) — $0 EDGAR
2024-05-23 Landos Biopharma, Inc. (LABP) Delisted Disp (D) — $0 EDGAR
2023-06-06 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) — $0 EDGAR
2023-05-24 Landos Biopharma, Inc. (LABP) Delisted Grant (A) — $0 EDGAR
2022-06-21 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) — $0 EDGAR
2022-06-09 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.